Savara SVRA
NASDAQ SVRA
$5.05 -0.11 (-2.23%)
At close: Oct 1, 2026 · 4:00 PM EDT

Savara (SVRA) EBITDA Margin (2015 - 2020)

Updated

Savara's EBITDA Margin came in at -1294600.00% for Q4 2020, down 1290411.72 percentage points from the prior quarter.

Analysis

Savara (SVRA) EBITDA Margin (2015 - 2020) Analysis & Trends

For FY2020, Savara's EBITDA Margin was -19083.66%.

  • EBITDA Margin carries a five-year change of -8385.51 percentage points (FY2015 to FY2020).
  • Going back by year, EBITDA Margin was -2712.25% in FY2016 (+7985.90 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 35.95%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 49.01%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 6.02%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 33.11%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 46.01%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -124.26%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 39.16%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 39.10%
10 Savara 1.06 Bn 1.06 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -1,294,600.00%
Sep 30, 2020 -4,188.28%
Mar 31, 2017 -5,067.02%
Dec 31, 2016 -1,007.75%
Sep 30, 2016 -7,124.44%
Dec 31, 2015 -17,912.96%
API Access

Savara EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SVRA&period=max&api_key=YOUR_API_KEY